Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.
Sekisui Medical Co., Ltd., Tokyo, Japan.
Thromb Haemost. 2021 Feb;121(2):164-173. doi: 10.1055/s-0040-1715838. Epub 2020 Aug 22.
Activated partial thromboplastin time (aPTT)-based clot waveform analysis is used to evaluate the comprehensive dynamics of fibrin clot formation. In addition, the technique can be usefully utilized for the rapid assessment of factor (F)VIII procoagulant activity in various clinical settings in patients with hemophilia A (HA). We defined a novel algorithm based on the weighted average parameters from aPTT-based waveforms to devise a template-matching procedure for assessing FVIII activity (FVIII:C).
The first derivatives of original clot waveforms triggered by the aPTT reagent (Coagpia APTT-N) were used to determine weighted averages of areas surrounded by the waveform at different percentages of maximum height in various clotting factor-deficient plasmas. Prepared templates based on 50 weighted average-related parameters were compared with 78 aPTT-prolonged plasmas.
Original nonsmoothed waveforms of the various clotting factor-deficient plasmas with prolonged aPTTs demonstrated a variety of shapes. The weighted averages were calculated after adjustments for different baselines, and the patterns seemed to be governed by the specific clotting factor deficiency. The weighted average-related parameters including baseline wedge ( = 0.998) and aspect ratio ( = 0.998) were highly correlated with FVIII:C levels. Template-matching analyses based on weighted average-related waveform parameters obtained from 158 samples demonstrated that the sensitivity was 97.2% and specificity was 83.3% in aPTT-prolonged plasmas ( = 78).
This novel algorithm based on weighted averages of aPTT-based waveforms together with template-matching may support clinical usefulness for judging of HA and may aid clinical management in the patients in the absence of specific clotting factor assays.
基于活化部分凝血活酶时间 (aPTT) 的凝块波形分析用于评估纤维蛋白凝块形成的综合动力学。此外,该技术可在血友病 A (HA) 患者的各种临床情况下,用于快速评估因子 (F)VIII 促凝活性。我们基于 aPTT 波形的加权平均参数定义了一种新算法,设计了一种模板匹配程序来评估 FVIII 活性 (FVIII:C)。
使用 Coagpia APTT-N 触发的原始凝块波形的一阶导数来确定在不同最大高度百分比的波形周围的面积的加权平均值,这些面积在各种凝血因子缺乏的血浆中。基于 50 个加权平均相关参数的制备模板与 78 个 aPTT 延长的血浆进行比较。
具有延长 aPTT 的各种凝血因子缺乏的血浆的原始非平滑波形表现出各种形状。在对不同基线进行调整后计算加权平均值,并且该模式似乎由特定的凝血因子缺乏决定。加权平均值相关参数包括基线楔形 ( = 0.998) 和纵横比 ( = 0.998) 与 FVIII:C 水平高度相关。基于从 158 个样本获得的加权平均相关波形参数的模板匹配分析表明,在 aPTT 延长的血浆中( = 78),敏感性为 97.2%,特异性为 83.3%。
这种基于 aPTT 波形加权平均值的新算法与模板匹配相结合可能支持对 HA 的临床有用性,并可能有助于在缺乏特定凝血因子检测的情况下为患者提供临床管理。